Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sunesis Pharmaceutic (SNSS)

Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 96,255
  • Shares Outstanding, K 18,093
  • Annual Sales, $ 2,070 K
  • Annual Income, $ -23,330 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.21
  • Price/Sales 29.96
  • Price/Cash Flow N/A
  • Price/Book 5.09
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.39
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.29
  • Number of Estimates 1
  • High Estimate -0.29
  • Low Estimate -0.29
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +42.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.35 +126.38%
on 01/28/21
7.09 -24.93%
on 02/24/21
+2.29 (+75.58%)
since 01/22/21
3-Month
1.33 +300.00%
on 11/25/20
7.09 -24.93%
on 02/24/21
+3.96 (+291.18%)
since 11/24/20
52-Week
1.12 +375.00%
on 11/06/20
11.30 -52.92%
on 02/26/20
-3.88 (-42.17%)
since 02/24/20

Most Recent Stories

More News
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers

WILMINGTON, Del., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

SNSS : 18.62 (+24.30%)
LOAC : 13.45 (+1.89%)
FBSS : 21.28 (+0.47%)
CPAH : 3.48 (+0.43%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of UROV, SNSS, TCF, and PS Mergers

WILMINGTON, Del., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

UROV : 16.24 (+0.06%)
SNSS : 18.62 (+24.30%)
TCF : 45.18 (-3.28%)
PS : 22.45 (+0.13%)
SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Sunesis Pharmaceuticals, Inc. (NasdaqGS:...

SNSS : 18.62 (+24.30%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of INFO, SNSS, INSU, and FBSS Mergers

WILMINGTON, Del., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

INFO : 21.28 (+0.92%)
SNSS : 18.62 (+24.30%)
FBSS : 21.28 (+0.47%)
INAQ : 10.38 (+0.19%)

Business Summary

Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. It has built a broad product candidate portfolio through internal discovery and in-licensing...

See More

Key Turning Points

3rd Resistance Point 9.13
2nd Resistance Point 8.11
1st Resistance Point 6.71
Last Price 18.62
1st Support Level 4.30
2nd Support Level 3.28
3rd Support Level 1.88

See More

Last Price 18.62
52-Week High 11.30
Fibonacci 61.8% 7.41
Fibonacci 50% 6.21
Fibonacci 38.2% 5.01
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar